Marvell Google AI Deal: What $120 Billion Really Means

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Marvell Technology (NASDAQ:MRVL) has suddenly become one of the most closely watched names in the custom AI-chip race. The Marvell Google AI deal could generate up to roughly $120 billion of custom-product revenue through fiscal 2033 if the required milestones are reached. Google also received warrants covering 58.97 million Marvell shares at $206.58 each. That could represent about $12.2 billion of stock if fully exercised.

The announcement sent Marvell shares sharply higher and put pressure on Broadcom, Google’s established custom-chip partner. But the headline number is only the beginning of the story. Marvell reports fiscal Q2 results on August 27, giving investors their first major financial checkpoint since the agreement was announced.

The central question is straightforward: how much of that $120 billion opportunity is actually likely to become revenue?

The Marvell Google AI Deal Is Bigger Than Marvell’s Current Base

The easiest way to understand the scale of the Google opportunity is to compare it with Marvell’s existing business.

Marvell generated a record $2.418 billion of revenue in fiscal Q1 2027, up 28% from the prior year. Data center revenue was $1.83 billion and represented 76% of company sales. Management then guided fiscal Q2 revenue to about...

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

Related Articles

Palo Alto Networks’ $4.5B AI Acquisition: What’s At Stake?

Palo Alto Networks (NASDAQ:PANW) is making another major move...

Freshworks Takeover Rumors: Who Could Buy It?

Freshworks Inc. (NASDAQ:FRSH) suddenly has a new question hanging...

Eli Lilly Acquisition: What Calytrix Bio Adds To Oncology

Eli Lilly and Company (NYSE:LLY) is making a move...

Diamondback Energy’s $5 Billion Double Eagle Acquisition Gamble

Diamondback Energy (NASDAQ:FANG) could be preparing another major move...

Tandem Diabetes Care: FDA Clears 7-Day Tubeless Pump

Tandem Diabetes Care (NASDAQ:TNDM) has secured an important regulatory...

CoreWeave Insider Selling: Why CEO Paused After $794 Million

CoreWeave (NASDAQ: CRWV) has given investors an unusual question...

Nvidia Jensen Scandal: Can Nvidia Survive Without Huang?

What happens when the man who helped build the...

Micron Stock Forecast: Could AI Fuel 148% Upside?

Micron Technology (NASDAQ: MU) has become one of Wall...
spot_img

Related Articles

Popular Categories

spot_imgspot_img